Back to newsArrivent Biopharma target price cut to $18 from $45AAVBP•2026-10-06Guggenheim cut its target price for Arrivent Biopharma to $18 from $45.Related NewsTNon-competitive bids for U.S. 6-week billsTLT•2026-10-06TAMEX halts TEMC; last price 38.44TEMC•2026-10-06SSphere Entertainment falls as BTIG cuts price target, citing softer bookingsSPHR•2026-10-06SAMEX halts SDEV; last price 4.18SDEV•2026-10-06PPfizer declares Q4 dividend of $0.43 per sharePFE•2026-10-06
AVBP•AVBP•AVBP•AVBP•
